Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-005007-26Phase 4Completed
Phase 4, randomised, open-label trial of triticum vulgare aqueous extract and benzydamine in bacterial vaginosis (BV), vaginitis and Vulvovaginitis (3 arms), sponsored by Farmaceutici Damor. Primary endpoint: Therapeutic success. Started Oct 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-005007-26.